Dongkook Pharmaceutical Co Ltd (086450)

KOSDAQ
Currency in KRW
15,230
+160(+1.06%)
Closed
086450 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
15,07015,410
52 wk Range
14,99020,600
Key Statistics
Edit
Bid/Ask
15,230.00 / 15,240.00
Prev. Close
15,070
Open
15,210
Day's Range
15,070-15,410
52 wk Range
14,990-20,600
Volume
59.79K
Average Volume (3m)
112.76K
1-Year Change
-13.71%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
086450 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
23,000
Upside
+51.02%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry
Show more

Dongkook Pharmaceutical Co Ltd Company Profile

DongKook Pharmaceutical Co., Ltd. produces and sell pharmaceutical products in South Korea and internationally. The company offers non-prescription and prescription drugs, quasi drugs, medical devices, active pharmaceutical ingredients, and cosmetics. Its pipeline includes DKF-310, which is in preclinical trials for the treatment of dementia; DKM-413, used for anesthetic; DKF-361, used to treat hypertension; DKF-325, an anticoagulant; DKM-412 and DKM-420 to treat osteoarthritis; DKF-313, that is in clinical studies, indicated for benign prostatic hyperplasia; DKF-340, a nonsteroidal anti-inflammatory drugs; DKM-415, indicated for synovial fluid replacement; DKF-334 and DKF-335 to treat osteoporosis; and DKF-363, for treatment of respiratory inflammation. In addition, the company develops DKB-119 and DKM-410, a biomaterial for tissue restoration; as well as develops new drugs for obesity and diabetes that is in preclinical studies. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. The company was founded in 1968 and is headquartered in Seoul, South Korea.

Employees
1131

Compare 086450 to Peers and Sector

Metrics to compare
086450
Peers
Sector
Relationship
P/E Ratio
10.9x5.3x−0.6x
PEG Ratio
0.360.020.00
Price/Book
1.2x0.8x2.6x
Price / LTM Sales
0.8x0.5x3.1x
Upside (Analyst Target)
52.6%53.8%53.1%
Fair Value Upside
Unlock30.5%7.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 23,000
(+51.02% Upside)

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-- / --
Revenue / Forecast
200.90B / 198.40B
EPS Revisions
Last 90 days

FAQ

What Is the Dongkook Pharmaceutical (086450) Stock Price Today?

The Dongkook Pharmaceutical stock price today is 15,230.00

What Stock Exchange Does Dongkook Pharmaceutical Trade On?

Dongkook Pharmaceutical is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Dongkook Pharmaceutical?

The stock symbol for Dongkook Pharmaceutical is "086450."

Does Dongkook Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Dongkook Pharmaceutical dividend yield is 1.08%.

What Is the Dongkook Pharmaceutical Market Cap?

As of today, Dongkook Pharmaceutical market cap is 662.60B.

What is Dongkook Pharmaceutical Earnings Per Share?

The Dongkook Pharmaceutical EPS is 1,401.94.

What Is the Next Dongkook Pharmaceutical Earnings Date?

Dongkook Pharmaceutical will release its next earnings report on 25 Feb 2025.

From a Technical Analysis Perspective, Is 086450 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.